Health Condition 1: K088- Other specified disorders of teethand supporting structures
Conditions
Interventions
Intervention1: platelet rich plasma: collection of gingival crevicular fluid following platelet rich plasma administration as an adjuvant on the experimental side during retraction phase with the conv
Sponsors
DR BHARAT KRISHNAN C K
Eligibility
Inclusion criteria
Inclusion criteria: class I bimaxillary malocclusion needing all first premolar extractions
Exclusion criteria
Exclusion criteria: Patients under any other medication which affects tooth movement Patients with craniofacial anomalies Patients with periodontal disease Patients with any kind of systemic disease that affects tooth movement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of ALP in the GCF of experimental side canine and molar and control side canine is evaluated.Timepoint: The GCF samples from the experimental canine and molar and control canine will be evaluated for the ALP levels using Human ALP ELISA test kit at T0(baseline), T1(21st day), T2(3rd month). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.The rate and amount of tooth movement in Platelet rich plasma administered side and non administered side 2.The anchorage loss on the experiment and non experiment side.Timepoint: 1.The amount and rate of tooth movement will be measured from the distal surface of canine and mesial surface of the second premolar at T0(before start of retraction), T1(1st month),T2(2nd month),T3(3rd month) and T4(4th month) 2.The lateral cephalogram will be taken at T0(baseline) and T1(3rd month)to assess the position of molar with respect to any stable landmark | — |
Countries
India
Contacts
Public ContactDR BHARAT KRISHNAN C K
FACULTY OF DENTAL SCIENCES, MS RAMAIAH UNIVERSITY OF APPLIED SCIENCES
Outcome results
None listed